Condition
Stimulant Dependence
Total Trials
7
Recruiting
1
Active
1
Completed
6
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 7 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
2 of 6 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
6Total
Not Applicable (3)
P 2 (3)
Trial Status
Completed6
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT03485417Phase 2Completed
Substance Misuse To Psychosis for Stimulants
NCT04449055Not ApplicableCompletedPrimary
Pilot TMS for Methamphetamine Use Disorder
NCT03470480Not ApplicableRecruiting
rTMS for Craving in Methamphetamine Use Disorder
NCT00842036Phase 2Completed
CRAFT Behavior Therapy: Treatment Entry Component
NCT01094223Not ApplicableCompletedPrimary
Mindfulness Based Relapse Prevention for Stimulant Users
NCT01863251Phase 2Completed
Atomoxetine for ATS and Opioid Dependence During Buprenorphine Maintenance Treatment in Malaysia
NCT00628927CompletedPrimary
An Eval of Neurocognitive Function, Oxidative Damage, and Their Association With Outcomes in METH and Cocaine Abusers.
Showing all 7 trials